KR920700003A - 향상된 광범위 살균제로서 사용하기 위한 신규의 박테리오신 조성물과 미생물 감염의 예방 및 처치방법 - Google Patents

향상된 광범위 살균제로서 사용하기 위한 신규의 박테리오신 조성물과 미생물 감염의 예방 및 처치방법

Info

Publication number
KR920700003A
KR920700003A KR1019900702363A KR900702363A KR920700003A KR 920700003 A KR920700003 A KR 920700003A KR 1019900702363 A KR1019900702363 A KR 1019900702363A KR 900702363 A KR900702363 A KR 900702363A KR 920700003 A KR920700003 A KR 920700003A
Authority
KR
South Korea
Prior art keywords
broad spectrum
fungicide
improved
group
lysostaphin
Prior art date
Application number
KR1019900702363A
Other languages
English (en)
Other versions
KR0145738B1 (ko
Inventor
블랙번 피터
구식 사라-안
폴락 쥰
디. 루비노. 스테펜
Original Assignee
원본미기재
더 퍼블릭 헬스 리서치 인스티튜트 오브 더 시티 오브 뉴욕, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 더 퍼블릭 헬스 리서치 인스티튜트 오브 더 시티 오브 뉴욕, 인코포레이티드 filed Critical 원본미기재
Publication of KR920700003A publication Critical patent/KR920700003A/ko
Application granted granted Critical
Publication of KR0145738B1 publication Critical patent/KR0145738B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

향상된 광범위 살균제로서 사용하기 위한 신규의 박테리오신 조성물과 미생물 감염의 예방 및 처치방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (23)

  1. 리소스타핀 및 란티오닌 함유 박테리오신으로 이루어진 조성물.
  2. 제 1 항에 있어서, 란티오닌 함유 박테리오신이니신, 서브틸린, 에피더민, 신나마이신, 듀라마이신, 안코배닌 및 Pep 5로 구성된 그룹에서 선택되는 조성물.
  3. 제 2 항에 있어서, 킬레이트제가 추가로 포함된 조성물.
  4. 제 3 항에 있어서, 계면 활성제가 포함된 조성물.
  5. 제 3 항에 있어서, 킬레이트제가 알킬디아민 테트라아세테이트, CaEDTA, Na2CaEDTA, EGTA 및 시트레이트로 구성된 그룹에서 선택되는 조성물.
  6. 제 5 항에 있어서, 알킬디아민 테트라아세테이트가 EDTA인 조성물.
  7. 제 4 항에 있어서, 계면 활성제가 트리톤, 트윈, 글리세리드, 유화제, 지방산, 4급화합물, 양성 및 음이온 계면 활성제로 구성된 그룹에서 선택되는 조성물.
  8. 담체, 리소스타핀 및 란티오닌 함유 박테리오신으로 이루어진 향상된 광범위 살균제.
  9. 제 8 항에 있어서, 란티오닌 함유 박테리오신이 니신, 서브틸린, 에피더민, 신나마이신, 듀라마이신, 안코베닌 및 Pep 5로 구성된 그룹에서 선택되는 향상된 광범위 살균제.
  10. 제 9 항에 있어서, 킬레이트제를 포함하는 향상된 광범위 살균제.
  11. 제 9 항에 있어서, 계면 활성제를 포함하는 향상된 광범위 살균제.
  12. 제 8 항에 있어서, 리소스타핀 및 란티오닌 함유 박테리오신은, 살균제가 스타필로코키 및 그람 양성 박테리아에 대해 향상된 활성을 가질 수 있는 충분한 양으로 존재하는 향상된 광범위 살균제.
  13. 제 10 항에 있어서, 리소스타핀, 란티오닌 함유 박테리오신 및 킬레이트제는, 살균제가 스타필로코키에 대해 그리고 그람 음성 및 그람 양성 박테리아로 구성된 그룹중 적어도 1종의 박테리아에 대해 향상된 활성을 가질 수 있는 양으로 존재하는 향상된 광범위 살균제.
  14. 제 11 항에 있어서, 계면 활성제는 박테이라가 스타필로코키에 대해 그리고 그람 음성 및 그람 양성 박테리아로 구성된 그룹중 적어도 1종에 대해 향상된 활성을 가질 수 있기에 충분한 양으로 존재하는 향상된 광범위 살균제.
  15. 제 10 항에 있어서, 킬레이트제가 알킬디아민 테트라아세테이트, EGTA 및 시트레이트로 구성된 그룹에서 선택되는 향상된 광범위 살균제.
  16. 제 15 항에 있어서, 알킬디아민 테트라아세테이트가 EDTA인 향상된 광범위 살균제.
  17. 제 11 항에 있어서, 계면 활성제가 트리톤, 트윈, 글리세리드, 지방산, 유화제, 4급 화합물, 양성 및 음이온 계면 활성제로 구성된 그룹에서 선택되는 향상된 광범위 살균제.
  18. 제 13 항에 있어서, 그람 음성 박테리아 표적물이 살모넬라 티피어륨, 에스케리키아 콜리, 콜레브시엘라 뉴모니아에, 슈도모나스 아에루기노사, 박테리오이드스 긴기발리스 및 악티노바실루스 악티노마이세테스코미탄스로 구성된 그룹에서 선택된 향상된 광범위 살균제.
  19. 제 13 항에 있어서, 그람 양성 박테리아 표적들이 포자형성 바실리, 스타필로코쿠스 아우레우스, 스트랩토코쿠스 뮤탄스, 리스테리아 모노시토겐스, 스테랩토코쿠스 아갈락티아에 및 코리네상 박테리아로 구성된 그룹에서 선택되는 향상된 광범위 살균제.
  20. 제 9 항에 있어서, 리소스타핀의 유효농도는 약 0.1 내지 100㎍/m1이고, 니신의 농도는 약 0.1 내지 300㎍/m1인 향상된 광범위 살균제.
  21. 제 10 항에 있어서, 리소스타핀의 농도는 약 0.1 내지 100㎍/m1이고, 란티오닌 함유 박테리오신의 농도는 약 0.1 내지 300㎍/m1이며, 킬레이트제의 농도는 약 0.1mM 내지 20mM인 향상된 광범위 살균제.
  22. 제 11 항에 있어서, 계면 활성제의 농도는 최종 용적의 약 0.01% 내지 1.0%인 향상된 광범위 살균제.
  23. ※ 참고사항 : 최초 출원 내용에 의하여 공개되는 것임.
KR1019900702363A 1989-03-01 1990-02-27 박테리오신 조성물 및 이를 함유하는 향상된 광범위 살균제 KR0145738B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/317,627 US4980163A (en) 1989-03-01 1989-03-01 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US317627 1989-03-01
US317,627 1989-03-01
PCT/US1990/001053 WO1990009739A1 (en) 1989-03-01 1990-02-27 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection

Publications (2)

Publication Number Publication Date
KR920700003A true KR920700003A (ko) 1992-02-19
KR0145738B1 KR0145738B1 (ko) 1998-08-01

Family

ID=23234535

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900702363A KR0145738B1 (ko) 1989-03-01 1990-02-27 박테리오신 조성물 및 이를 함유하는 향상된 광범위 살균제

Country Status (21)

Country Link
US (1) US4980163A (ko)
EP (1) EP0424484B1 (ko)
JP (1) JP2984744B2 (ko)
KR (1) KR0145738B1 (ko)
AT (1) ATE109624T1 (ko)
AU (1) AU618714B2 (ko)
CA (1) CA2028140C (ko)
CZ (1) CZ279273B6 (ko)
DD (1) DD301903A9 (ko)
DE (1) DE69011460T2 (ko)
DK (1) DK0424484T3 (ko)
FI (1) FI103861B (ko)
HU (1) HU217574B (ko)
IE (1) IE64710B1 (ko)
IL (1) IL93527A (ko)
NO (1) NO304721B1 (ko)
NZ (1) NZ232700A (ko)
PL (1) PL163940B1 (ko)
RU (1) RU2048151C1 (ko)
WO (1) WO1990009739A1 (ko)
ZA (1) ZA901499B (ko)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858962A (en) * 1987-05-11 1999-01-12 Ambi Inc. Composition for treating mastitis and other staphylococcal infections
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
DE3938140A1 (de) * 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
NO911341L (no) * 1990-04-20 1991-10-21 Haarmann & Reimer Corp Fremgangsmaate for aa drepe gram-negative bakterier.
US5559096A (en) * 1991-04-15 1996-09-24 Applied Microbiology, Inc. Pharmaceutical compositions against gastric disorders
GB9126686D0 (en) * 1991-12-17 1992-02-12 Smithkline Beecham Plc Novel compositions
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
EP0629347B1 (en) * 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
DE4229707A1 (de) * 1992-09-05 1994-03-10 Beiersdorf Ag Germicide Wirkstoffkombinationen
JPH08504401A (ja) * 1992-10-29 1996-05-14 デネッケ，ライナー 消化管疾患の治療および特に予防用製剤
DE4307352A1 (de) * 1992-10-29 1994-05-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US5368845A (en) * 1993-01-07 1994-11-29 Colgate Palmolive Company Oral composition
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
AU689494B2 (en) * 1993-08-20 1998-04-02 Boehringer Ingelheim Vetmedica Gmbh Method for the prevention and treatment of bovine mastitis
CA2121989A1 (en) * 1993-11-18 1995-05-19 Aloysius Knipper Thermal abuse resistant egg
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
US5762948A (en) * 1995-06-07 1998-06-09 Ambi Inc. Moist bacteriocin disinfectant wipes and methods of using the same
US5866539A (en) * 1995-06-23 1999-02-02 Ambi Inc. Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
US5703040A (en) * 1995-11-22 1997-12-30 Kansas State University Research Foundation Broad spectrum antibiotic peptide
US5804549A (en) * 1996-01-05 1998-09-08 Ambi Inc. Compositions with activity against helicobacter
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US6238377B1 (en) 1997-01-27 2001-05-29 Jin-Zhou Liu Nasal-nasopharyngeal cleaning system
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US6315996B1 (en) 1999-04-09 2001-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Topical lysostaphin therapy for staphylococcus ocular infections
US6187768B1 (en) 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
US6342385B1 (en) 2000-07-28 2002-01-29 The Uab Research Foundation Mutacin I biosynthesis genes and proteins
EP1362089B1 (en) * 2001-02-17 2007-01-03 Novozymes A/S Reduction of malodour from laundry
US7572439B2 (en) * 2002-03-26 2009-08-11 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
EP1560540A4 (en) * 2002-10-18 2008-03-19 Molichem Medicines Inc METHOD FOR TREATING DRY EYES WITH LANTIBIOTICS
CA2508796A1 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20100221237A1 (en) * 2003-03-26 2010-09-02 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
US6989370B2 (en) * 2003-05-01 2006-01-24 The United States Of America As Represented By The Secretary Of Agriculture Bacteriocins and novel bacterial strains
JP4926707B2 (ja) * 2003-08-22 2012-05-09 ダニスコ エイ／エス 封入化抗菌材料
MXPA06002068A (es) * 2003-08-22 2006-05-19 Danisco Material antimicrobiano encapsulado.
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
EP1858482B1 (en) 2005-03-10 2014-04-23 3M Innovative Properties Company Methods of reducing microbial contamination
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
US8476319B2 (en) 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
US8124016B2 (en) * 2005-11-15 2012-02-28 Lg Electronics, Inc. Articles with antimicrobial property and manufacturing method thereof
ATE470451T1 (de) * 2006-03-31 2010-06-15 Univ St Andrews Antimikrobielle zusammensetzungen mit einem kationischen peptid und glycylglycin- endopeptidase
US8747872B2 (en) * 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
WO2009150171A1 (en) * 2008-06-10 2009-12-17 Profos Ag Method of treatment of inflammatory diseases
US8425968B2 (en) * 2009-06-19 2013-04-23 Pepsico., Inc. Beverage preservative system containing pimaricin-cyclodextrin complex
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
US20140090833A1 (en) * 2012-09-28 2014-04-03 Halliburton Energy Services, Inc. Methods for Treating Wellbore and Wellbore Operation Fluids
RU2629819C1 (ru) * 2016-08-23 2017-09-04 Федеральное бюджетное учреждение науки "Казанский научно-исследовательский институт эпидемиологии и микробиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Антибактериальная композиция на основе хитозана и лизостафина
CN113396937A (zh) * 2020-03-17 2021-09-17 孟州云大高科生物科技有限公司 一种多酶与生物类杀菌剂的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744827A (en) * 1951-03-07 1956-05-08 Nat Res Dev Manufacture and preservation of cheese
GB738655A (en) * 1952-05-09 1955-10-19 Aplin & Barrett Ltd A dry nisin preparation
US3278378A (en) * 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US3579354A (en) * 1968-08-01 1971-05-18 Beatrice Foods Co Preparation of an elastic cheese product
US3899594A (en) * 1971-09-13 1975-08-12 Dirigo Corp Food preservation
US3988307A (en) * 1974-09-06 1976-10-26 The United States Of America As Represented By The Secretary Of The Department Of Health, Education And Welfare Solid phase synthesis of peptides with carboxyl-terminal amides
PL193146A1 (pl) * 1976-10-19 1978-04-24 Inst Przemyslu Mleczarskiego Preparat enzymatyczny do dojrzewania bialkowych produktow mleczarskich
US4318928A (en) * 1979-12-19 1982-03-09 Sing Edmond L Preparation of cottage cheese containing Streptococcus diacetilactis
US4477471A (en) * 1982-04-15 1984-10-16 Microlife Technics, Inc. Preservation of foods with non-lactose fermenting Streptococcus Lactis subspecies diacetilactis
US4597972A (en) * 1983-06-10 1986-07-01 Aplin & Barrett, Ltd. Nisin as an antibotulinal agent for food products
US4584199A (en) * 1983-06-10 1986-04-22 Aplin & Barrett, Ltd. Antibotulinal agents for high moisture process cheese products
US4716115A (en) * 1983-09-06 1987-12-29 Microlife Technics, Inc. Derived nisin producing microorganisms, method of production and use and products obtained thereby
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US4929445A (en) * 1988-01-25 1990-05-29 Microlife Technics, Inc. Method for inhibiting Listeria monocytogenes using a bacteriocin

Also Published As

Publication number Publication date
HU902849D0 (en) 1991-05-28
AU5285090A (en) 1990-09-26
PL284095A1 (en) 1992-09-21
KR0145738B1 (ko) 1998-08-01
AU618714B2 (en) 1992-01-02
NO904729L (no) 1990-11-15
ATE109624T1 (de) 1994-08-15
NO304721B1 (no) 1999-02-08
FI905378A0 (fi) 1990-10-31
EP0424484A1 (en) 1991-05-02
IE900721L (en) 1990-09-01
IL93527A0 (en) 1990-11-29
US4980163A (en) 1990-12-25
JP2984744B2 (ja) 1999-11-29
ZA901499B (en) 1990-11-28
PL163940B1 (pl) 1994-05-31
CZ279273B6 (cs) 1995-03-15
IE64710B1 (en) 1995-08-23
FI103861B1 (fi) 1999-10-15
IL93527A (en) 1995-03-15
NZ232700A (en) 1992-10-28
DD301903A9 (de) 1994-06-30
CA2028140A1 (en) 1990-09-02
FI103861B (fi) 1999-10-15
JPH03504864A (ja) 1991-10-24
DE69011460T2 (de) 1994-12-22
EP0424484B1 (en) 1994-08-10
HUT55607A (en) 1991-06-28
HU217574B (hu) 2000-02-28
WO1990009739A1 (en) 1990-09-07
DE69011460D1 (de) 1994-09-15
CA2028140C (en) 1996-12-03
NO904729D0 (no) 1990-10-31
DK0424484T3 (da) 1994-10-03
RU2048151C1 (ru) 1995-11-20

Similar Documents

Publication Publication Date Title
KR920700003A (ko) 향상된 광범위 살균제로서 사용하기 위한 신규의 박테리오신 조성물과 미생물 감염의 예방 및 처치방법
US5217950A (en) Nisin compositions for use as enhanced, broad range bactericides
US5260271A (en) Nisin compositions for use as enhanced broad range bactericides
EP0545911B1 (en) Lanthionine-containing bacteriocin compositions for use as bactericides
US5135910A (en) Nisin compositions for use as enhanced, broad range bactericides
KR900700015A (ko) 향상된, 광범위 살균제로서 사용하기 위한 니신 조성물
JPH07196408A (ja) 抗菌性組成物
GB1181096A (en) The Antibiotic Lincomycins
KR940001892A (ko) 세피오리소짐을 활성성분으로 하는 심장기능 촉진제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020427

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee